ApoB Goal Cost-Effective in Primary Prevention - Takeaway - MDSpire
From the Journals

ApoB Goal Cost-Effective in Primary Prevention

Strategy increased quality-adjusted life-years and showed favorable cost-effectiveness vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol goals

Share

  • 1

    ApoB targeting improves ASCVD prevention over LDL-C/non-HDL-C strategies.

  • 2

    1,324 additional quality-adjusted life-years gained.

  • 3

    Incremental cost-effectiveness ratio: $30,300 per QALY.

  • 4

    Study used 250,000 statin-eligible adults.

  • 5

    Higher treatment intensification rates seen with ApoB.

  • 6

    Supported by American Heart Association.

  • 7

    Findings highlight need for better treatment guidance in primary prevention.

Original Source(s)

ApoB Goal Cost-Effective in Primary Prevention

  • by Kathryn Wighton

  • April 15, 2026

Related Content

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Is Long COVID Affecting the Heart?

Study points to increased cardiovascular events post-infection

  • April 17, 2026

  • 2 min
Top 10 Evidence-Based Essentials in Cardiology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice